Bone & Joint Care in China
Joint preservation, microsurgical replantation, and patient-specific 3D-printed reconstruction — built around your next decision, often at a fraction of US cost.
If you have been told you need a knee replacement, hip replacement, spine fusion, or complex bone reconstruction, it may be worth taking a closer look first.
China's orthopedic centers combine China-developed surgical robotics (TiRobot, used in over 110,000 procedures across 200+ hospitals), innovative biomaterials (the COLTRIX cartilage scaffold and Bone-02 fracture adhesive — both China-NMPA-approved firsts), and high-volume experience across the full treatment spectrum — from joint preservation to 3D-printed custom reconstruction. The hardest question is often not whether treatment exists; it is whether the treatment recommended to you is truly the right next step.
MediPath coordinates pre-arrival expert review and hospital matching to help you decide.
Globally-leading Chinese biologics for inflammatory and autoimmune joint disease.
China's musculoskeletal drug pipeline is anchored by telitacicept — the world's first BAFF/APRIL dual-target biologic, approved 2021 — alongside the first selective Chinese JAK1 inhibitor ivarmacitinib and two new biologics in NMPA review (QX002N/crusekitug and TRD221). For international patients with inflammatory or autoimmune joint disease, this is access to globally-leading Chinese-originated biologics not yet available outside China.
World's 1st
dual BAFF/APRIL-targeting biologic (telitacicept, 2021) — no other approved biologic targets both pathways in a single molecule[R3-R4]
70.4–75.1%
ACR20 response with ivarmacitinib (4 mg / 8 mg) at Week 24 versus 40.4% with placebo in Phase III rheumatoid arthritis[R1-R2]
2 in review
additional China-originated joint/autoimmune biologics advancing through NMPA review — QX002N (IL-17A) and TRD221 (osteoarthritis)[R5][R6]
Doing less when less is enough — and more, more precisely, when complexity demands it.
China's musculoskeletal surgical pathway begins with what doesn't need replacement, fusion, or major reconstruction — joint preservation, microsurgical replantation, patient-specific 3D-printed reconstruction. The world's first published hand replantation was performed in Shanghai in 1963 by Chen Zhongwei; today his pathway anchors China's microsurgery and limb-salvage care.
1963
year of the world's first published successful limb replantation — Shanghai Sixth People's Hospital (Prof. Chen Zhongwei)[R18-R19]
96
patient cohort of 3D-printed custom hemipelvic reconstruction at West China Hospital, with sustained functional gains and reduced pain[R9]
7–10 mm
incision for endoscopic lumbar spine decompression (PELD/PTED/UBE) — an alternative to open or fusion surgery, at high Chinese case volume[R8]
Chinese biomaterials and devices, proven at clinical scale.
China-developed platforms span the full bone & joint care journey: TiRobot (NMPA-approved domestic orthopedic surgical robot, deployed at 200+ Chinese hospitals), the COLTRIX collagen scaffold for cartilage repair (NMPA Innovative Medical Device 2023), the Bone-02 injectable bone adhesive (frontier biomaterial), domestic 3D-printed titanium endoprosthesis systems, and lower-limb rehabilitation robotics. The story is Chinese biomaterials and devices increasingly proven at clinical scale.
2023
NMPA approval of the China-developed COLTRIX collagen scaffold for cartilage repair — an innovative-device first[R10]
~3 min
bone-fragment fixation time reported with the Bone-02 injectable adhesive via a 2–3 cm incision (Sir Run Run Shaw Hospital)[R15]
2 platforms
China-developed orthopedic surgical robots approved by NMPA for hip/knee arthroplasty — TiRobot (Tinavi) and SkyWalker (MicroPort)[R13-R14]
Signature Institutions for Bone & Joint Care in China
Beijing Jishuitan Hospital
北京积水潭医院
Beijing
Spine, joint, trauma, hand, sports orthopedics, robotic surgery
Peking University Third Hospital
北京大学第三医院
Beijing
Sports medicine, 3D-printed implants, spine surgery
Huashan Hospital, Fudan University
复旦大学附属华山医院
Shanghai
Spine surgery, sports medicine, hand microsurgery
Shanghai Sixth People's Hospital
上海交通大学医学院附属第六人民医院
Shanghai
Orthopedic trauma, limb reconstruction, microsurgery
University of Hong Kong-Shenzhen Hospital
香港大学深圳医院
Shenzhen
Orthopedics under HKU clinical standards, joint replacement
Request a Bone & Joint Case Review
Share your diagnosis, imaging (X-ray, CT, MRI), prior treatment history, and the surgery that has been recommended to you. Our team can help identify whether China offers a relevant second opinion — joint preservation before replacement, microsurgical or limb-salvage reconstruction, endoscopic spine surgery, or access to China-originated biologics — or faster, lower-cost access to a pathway for your condition.